PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy

PHASE4CompletedINTERVENTIONAL

Enrollment

420

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Malignant Solid Tumors

Interventions

DRUG

PEG-rhG-CSF

All Listed Sponsors

lead

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

INDUSTRY

NCT02805166 - PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy | Biotech Hunter | Biotech Hunter